Validating the predictive ability of the 2MACE score for major adverse cardiovascular events in patients with atrial fibrillation: results from phase II/III of the GLORIA-AF registry. Optimal anti ...

Background A 60-year-old male with obesity (body-mass index 43 kg/m 2) presented with recurrent symptomatic atrial fibrillation (AF), which he had had since age 41 years. The AF was refractory to ...

A velocity of < 0.4 m/s indicates a higher risk, in general, of thromboembolism. Cardiac CT can be used, as well. During atrial fibrillation and atrial flutter, the left atrial appendage loses ...

Atrial flutter is similar to atrial fibrillation (AF) in regard to symptoms and thromboembolic risk, including stroke. However, the pathophysiology and management differ. Symptoms of AF reflect ...

In this randomized controlled trial, abelacimab led to significantly lower rates of major or clinically relevant nonmajor ...

This leads to stagnant blood in the appendage, which causes clot formation ( thrombosis). Risk factors for atrial fibrillation include: The heart's main pumping chambers, the ventricles ...

In this randomized controlled trial, among patients with atrial fibrillation requiring anticoagulation therapy, asundexian ...

Discover how botanical and nutrient therapies provided adjunctive support for a 76-year-old patient with treatment-resistant ...

subclinical atrial fibrillation, venous thromboembolism, or stroke. The risk for major bleeding and intracranial hemorrhage did not differ between apixaban and aspirin (absolute risk difference ...

Background: There was limited evidence on the clinical benefits of the concomitant Cox-Maze procedure with aortic valve replacement (AVR) in patients ...